Summary:
The RESET Study is a randomized, double-blind, placebo-controlled, Phase 4 study, that is aiming to enroll approximately 1100 patients with recurrent depression at approximately 60 study centers across the United States.
Qualified Participants Must:
• Have current major depression which has lasted 2-18 months
•
Have had at least two previous major depressive episodes
•
Be between 18-75 years of age, inclusive
Qualified Participants May Receive:
If eligible, compensation for time and travel.